Mutagenesis of the human IgA1 heavy chain tailpiece that prevents dimer assembly

Journal of Immunology

Volumn 157, Issue 1, 1996, Pages 156-159

  Atkin, Julie D ^a,c   Pleass, Richard J ^a   Owens, Ray J ^b   Woof, Jenny M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UCB PHARMA   (Belgium)

^c AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A1; IMMUNOGLOBULIN HEAVY CHAIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; DIMERIZATION; GENE DELETION; HUMAN; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION;

ANIMALS; BASE SEQUENCE; BIOPOLYMERS; GENETIC VECTORS; HUMANS; IMMUNOGLOBULIN A; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 0030003017     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Davis, A. C., and M. J. Shulman. 1989. IgM-molecular requirements for its assembly and function. Immunol. Today 10:118.
2. Mendez, E., F. Prelli, B. Frangione, and E. C. Franklin. 1973. Characterization of a disulfide bridge linking the J chain to the α chain of polymeric immunoglobulin A. Biochem. Biophys. Res. Commun. 55:1291.
3. Mestecky, J., R. E. Schrohenloher, R. Kulhavy, G. P. Wright, and M. Tomana. 1974. Site of J chain attachment to human polymeric IgA. Proc. Natl. Acad. Sci. USA 71:544.
4. Davis, A. C., C. Collins, M. I. Yoshimara, G. D'Agostaro, and M. J. Shulman. 1989. Mutations of the mouse μ H chain which prevent polymer assembly. J. Immunol. 43:1352.
5. Cann, G. M., A. Zaritsky, and M. E. Koshland. 1982. Primary structure of the immunoglobulin J chain from mouse. Proc. Natl. Acad. Sci. USA 79:6656.
6. Kerr, M. A. 1990. The structure and function of human IgA. Biochem. J. 271:285.
7. Brandtzaeg, P. 1981. Transport models for secretory IgA and secretory IgM. Clin. Exp. Immunol. 44:221.
8. Mostov, K. E. 1994. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12:63.
9. Underdown, B. J., and J. M. Schiff. 1986. Immunoglobulin A: strategic defense initiative at the mucosal surface. Annu. Rev. Immunol. 4:389.
10. Morton, H. C., J. D. Atkin, R. J. Owens, and J. M. Woof. 1993. Purification and characterization of chimeric human IgA1 and IgA2 expressed in COS and Chinese hamster ovary cells. J. Immunol. 151:4743.
11. Whittle, N., J. Adair, C. Lloyd, L. Jenkius, J. Devine, I. Schlom, A. Raubitschek, D. Colcher, and M. Bodmer. 1987. Expression in COS cells of a mouse-human chimaeric B72.3 antibody. Protein Engin. 1:499.
12. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
13. Chen, E. Y., and P. H. Seeburg. 1985. Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA 4:165.
14. Neumann, E., M. Schaefer-Ridder, Y. Wang, and P. H. Hofschneider. 1982. Gene transfer into mouse lymphoma cells by electroporation in high electric fields. EMBO J. 1:841.
15. Laemmli, E. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
16. Kaji, H., and R. M. E. Parkhouse. 1974. Intracellular J chain in mouse plasmacytomas secreting IgA, IgM and IgG. Nature 249:45.
17. Lundblad, A., R. Steller, E. A. Kabat, J. W. Hirst, M. G. Weiger, and M. Cohn. 1972. Immunochemical studies on mouse myeloma proteins with specificity for dextran or for levan. Immunochemistry 9:535.
18. Cattaneo, A., and M. S. Neuberger. 1987. Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. EMBO J. 6:2753.
19. Chapuis, R. M., and M. E. Koshland. 1975. Linkage and assembly of polymeric IgA immunoglobulins. Biochemistry 14:1320.
20. Despont, J.-P. J., C. A. Abel, H. M. Grey, and G. M. Penn. 1974. Structural studies on human IgA1 myeloma protein with a carboxyl-terminal deletion. J. Immunol 112:1517.
21. Robinson, E. A., and E. Appella. 1980. Complete amino acid sequence of a mouse immunoglobulin α chain MOPC 511. Proc. Natl. Acad. Sci. USA 8:4909.
22. Kabat, E. A., T. T. Wu, M. Reid-Miller, H. M. Perry, and K. S. Gottesman. 1987. Sequences of Proteins of Immunological Interest, 4th Ed. U.S. Department of Health and Human Services, Washington, D.C.
23. Fra, A. M., C. Fagioli, D. Finazzi, R. Sitia, and C. M. Alberini. 1993. Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation. EMBO J. 12:4755.
24. Koshland, M. E. 1985. The coming of age of J chain. Annu. Rev. Immunol. 3:425.
25. Bastian, A., H. Kratzin, K. Eckhart, and N. Hilschmann. 1992. Intra- and interchain disulphide bridges of the human J chain in secretory immunoglobulin A. Biol. Chem. Hoppe-Seyler 373:1255.
26. Gregor, P. D., and S. L. Morrison. 1988. The IgA myeloma W3129 contains a deletion in the CH3 which prevents the formation of the membrane form of the heavy chain mRNA. Mol. Immunol. 25:495.
27. Feinstein, A., E. A. Munn, and Richardson N. E. 1971. The three-dimensional conformation of γM and γA globulin molecules. Ann. NY Acad. Sci. 190:104.
28. Svehag, S. E., and B. Bloth. 1970. Ultrastructure of secretory and high-polymer serum IgA of human and rabbit origin. Science 168:847.
29. Prahl, J. W., C. A. Abel, and H. M. Grey. 1971. The carboxy-terminal structure of the α chain of human IgA myeloma proteins. Biochemistry 10:1808.
30. Sitia, R., M. Neuberger, C. Alberini, P. Bet, A. Fra, C. Valetti, G. Williams, and C. Milstein. 1990. Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell 60:781.
31. Field, M. C., S. Amatayakul-Chantler, T. W. Rademacher, P. M. Rudd, and R. A. Dwek. 1994. Structural analysis of the N-glycans from human immunoglobulin AI: comparison of normal human serum immunoglobulin AI with that isolated from patients with rheumatoid arthritis. Biochem. J. 299:261.
32. Bernier, G. M., C. A. Johnson, and M. W. Fanger. 1977. Structural and biosynthetic studies of a human IgA half molecule. J. Immunol. 119:1260.
33. Spiegelberg, H. L., and B. G. Fishkin. 1976. Human myeloma IgA half-molecules. J. Clin. Invest. 58:1259.
34. Jerry, L. M., and H. G. Kunkel. 1972. The unique reassociation of human IgA2 immunoglobulins from dimer subunits. J. Immunol. 109:982.
35. Shopes, B. 1992. A genetically engineered human IgG mutant with enhanced cytolytic activity. J. Immunol. 148:2918.
36. Caron, P. C., W. Laird, M. Sung Co, N. M. Avdalovic, C. Queen, and D. A. Scheinberg. 1992. Engineered humanized dimeric forms of IgG are more effective antibodies. J. Exp. Med. 176:1191.
37. Smith, R. I. F., M. J. Coloma, and S. L. Morrison. 1995. Addition of a μ-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4. J. Immunol. 154:2226.